Skip to content
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also ...
Read More
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough ...
Read More
BIO 2025 IP Conference: Challenging times for the laws that drive innovation
Patents offer the intellectual property protections investors need to support biotech innovation. That’s ...
Read More
National Family Caregivers Month: Recognizing 63 million Americans
November is National Family Caregivers Month, and to mark the occasion, Bio.News sat ...
Read More
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by ...
Read More
BIO Coffee Chat: Guiding patients through Part D open enrollment
Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Health
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to attract ...
Federal Policy
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research and ...
BIO Events
BIO 2025 IP Conference: Challenging times for the laws that drive innovation
Patents offer the intellectual property protections investors need to support biotech innovation. That’s why the Biotechnology Innovation Organization (BIO) annual IP Council and Committees (IPC) ...
Latest News
National Family Caregivers Month: Recognizing 63 million Americans
November is National Family Caregivers Month, and to mark the occasion, Bio.News sat down with the National Alliance for Caregiving (NAC) to discuss the crucial ...
BIO's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines, a ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are ...
Read More
International
Bio's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely ...
Read More
